Sean R. Bennett MD, PhD

Dr Bennett joined PaxVax in 2016 to lead clinical development activities across its portfolio of vaccines. Prior to joining PaxVax, Dr Bennett led the pediatric antiretroviral development team at Gilead. His previous vaccine development experience includes evaluation of novel adjuvants for vaccines and immunotherapeutics against tuberculosis, hepatitis B, and HIV. Dr Bennett received his MD and PhD (Immunology) degrees from the University of Colorado and trained in pediatrics at Dartmouth.